Profilo
Ed Bell worked as an Investor Relations Contact at CTI BioPharma Corp.
from 2008 to 2018.
Precedenti posizioni note di Ed Bell
| Società | Posizione | Fine |
|---|---|---|
| CTI BIOPHARMA CORP. | Contatto Relazioni con gli Investitori | 01/04/2018 |
Esperienze
Posizioni ricoperte
Relazioni
22
Relazioni di 1° grado
1
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Ed Bell
